PAXLOVID cpr pell 4x150mg/2x100mg 5 x 6 pce

7680687930017 Pharmacode 7825744 CH-68793 J05AE30 08.03.0.
PAXLOVID cpr pell 4x150mg/2x100mg 5 x 6 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

GTIN
7680687930017
Pharmacode
7825744
Product number
6879301
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
A): nirmatrelvirum 150 mg, cellulosum microcristallinum, lactosum monohydricum 185 mg, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), pro compresso obducto corresp. natrium 0.99 mg. B): ritonavirum 100 mg, copovidonum, silica colloidalis anhydrica, sorbitani lauras, calcii hydrogenophosphas, natrii stearylis fumaras, Überzug: hypromellosum, E 171, macrogolum 400, macrogolum 3350, hydroxypropylcellulosum, talcum, silica colloidalis anhydrica, polysorbatum 80, pro compresso obducto, natrium 0.388 mg.

Articles (1)

Paxlovid, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
30/09/2026
Patient information leaflet
Français
30/09/2026
Patient information leaflet
Italien
30/09/2026
Professional SmPC
Allemand
30/09/2026
Professional SmPC
Français
30/09/2026
Professional SmPC
Italien
30/09/2026

Detailed composition

Substance Quantity Type Category
ritonavirum
100.0 MG Substance Wirkstoff (Principe actif)
nirmatrelvirum
150.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum
- Substance HNIDK
copovidonum
- Substance HNIDK
lactosum monohydricum
185.0 MG Substance HBESI
silica colloidalis anhydrica
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
sorbitani lauras
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
calcii hydrogenophosphas
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
macrogolum 3350
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
hydroxypropylcellulosum
- Substance HNIDK
talcum
- Substance HNIDK
natrium
0.99 MG Substance HBESI
silica colloidalis anhydrica
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
natrium
0.388 MG Substance HBESI

Reimbursement information

Public price
CHF 1058.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2023

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
68793
Drug name
Paxlovid, Filmtabletten
Galenic form
FILM
ATC Code
J05AE30
Authorization status
Z
Dispensation category
A
First authorization
15/06/2022
Authorization expiration date
04/04/2029
IT number
08.03.0.
Domain
Human medicine
Field of application
Behandlung der Coronavirus-Krankheit 2019 (COVID-19) bei pädiatrischen Patienten ab 6 Jahren mit einem Körpergewicht von mindestens 20 kg, die keine Sauerstofftherapie oder Hospitalisierung aufgrund von COVID-19 benötigen und bei denen ein erhöhtes Risiko für einen schweren Verlauf von COVID-19 besteht.

Packaging details

Description (FR)
PAXLOVID cpr pell 4x150mg/2x100mg 5 x 6 pce
Description (DE)
PAXLOVID Filmtabl 4x150mg/2x100mg 5 x 6 Stk
Market launch
15/06/2022
Narcotic (BTM)
No
Buy us a coffee Explore the data